Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

MND, ALS... HERVs... ARVs...

Discussion in 'Active Clinical Studies' started by merylg, Sep 28, 2016.

  1. merylg

    merylg Senior Member

    Messages:
    824
    Likes:
    637
    Sydney, NSW, Australia
  2. merylg

    merylg Senior Member

    Messages:
    824
    Likes:
    637
    Sydney, NSW, Australia
  3. ukxmrv

    ukxmrv Senior Member

    Messages:
    4,322
    Likes:
    4,358
    London
    "The Lighthouse Project is the first Phase 2 clinical trial in the world to use modern combination anti-retroviral therapy in patients with MND. The study aims to determine the safety and tolerability of an anti-retroviral therapy “Triumeq” and provide preliminary data on whether it is able to slow down the progression of MND. Triumeq is already used to treat HIV infection safely and effectively. "

    and

    "The Lighthouse Project is supported by the Motor Neurone Disease Research Institute of Australia and the Cure for MND Foundation."
     
    merylg likes this.

See more popular forum discussions.

Share This Page